CoChat

INSULIN AS A VASCULAR HORMONE: IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASE

Cleland, Stephen J, Petrie, John R, Ueda, Shinichiro, Elliott, Henry L, Connell, John MC · 1998 · Clinical and Experimental Pharmacology and Physiology
Cited by 102

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

1. Metabolic disorders, such as obesity and non‐insulin‐dependent diabetes mellitus, and cardiovascular disorders, such as essential hypertension, congestive cardiac failure and atherosclerosis, have two features in common, namely relative resistance to insulin‐mediated glucose uptake and vascular endothelial dysfunction. 2. Significant increases in limb blood flow occur in response to systemic hyperinsulinaemia, although there is marked variation in the results due to a number of confounding factors, including activation of the sympathetic nervous system. Local hyperinsulinaemia has a less marked vasodilator action despite similar plasma concentrations, but this can be augmented by co‐infusing D‐glucose. 3. Insulin may stimulate endothelial nitric oxide production or may act directly on vascular smooth muscle via stimulation of the Na+–H+ exchanger and Na+/K+‐ATPase, leading to hyperpolarization of the cell membrane and consequent closure of voltage‐gated Ca 2+ channels. 4. There is evidence both for and against the existence of a functional relationship between insulin‐mediated glucose uptake (insulin sensitivity) and insulin‐mediated vasodilation (which can be regarded as a surrogate measure for endothelial function). 5. If substrate delivery is the rate‐limiting step for insulin‐mediated glucose uptake (in other words, if skeletal muscle blood flow is a determinant of glucose uptake), then endothelial dysfunction, resulting in a relative inability of mediators, including insulin, to stimulate muscle blood flow, may be the underlying mechanism accounting for the association of atherosclerosis and other cardiovascular disorders with insulin resistance. 6. Glucose uptake may determine peripheral blood flow via stimulation of ATP‐dependent ion pumps with consequent vasorelaxation. 7. A ‘third factor’ may cause both insulin resistance and endothelial dysfunction in cardiovascular disease. Candidates include skeletal muscle fibre type and capillary density, distribution of adiposity and endogenous corticosteroid production. 8. A complex interaction between endothelial dysfunction, abnormal skeletal muscle blood flow and reduced insulin‐ mediated glucose uptake may be central to the link between insulin resistance, blood pressure, impaired glucose tolerance and the risk of cardiovascular disease. An understanding of the primary mechanisms resulting in these phenotypes may reveal new therapeutic targets in metabolic and cardiovascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1681.1998.t01-15-.x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 102

Metadata

Authors
Cleland, S. J., Petrie, J. R., Ueda, S., Elliott, H. L., & Connell, J. M.
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
1998-03
Volume
25
Issue
3-4
Pages
175-184
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W2164124107
Cited by
102
References
16
FWCI
5.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: INSULIN AS A VASCULAR HORMONE: IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASE. https://app.cochat.ai/papers/10.1111/j.1440-1681.1998.t01-15-.x
The paper
Cleland, S. J., Petrie, J. R., Ueda, S., Elliott, H. L., & Connell, J. M. (1998). INSULIN AS A VASCULAR HORMONE: IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASE. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/j.1440-1681.1998.t01-15-.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.